Last update: Aug. 23, 2021


High Risk for breastfeeding

Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives).
Read the Comment.

Barbiturate with general properties similar to those of amobarbital. Hypnotic and sedative.
It is used to treat pain in preparations combined with paracetamol or caffeine.
Discontinued medication due to risk of overdose and abuse (Suddock 2020).

At the date of the last update, there was no available published data on its excretion in breast milk.

Its pharmacokinetic data (low molecular weight, low protein binding, prolonged half-life) make it probable that it will pass to milk in an amount that could be significant.

A 7-day-old newborn, whose mother was taking a butalbital (50 mg) -paracetamol-caffeine compound four times a day, presented sedation, lethargy, hypotonia, insufficient feeding and vomiting. The infant had butalbital levels in its urine(Vohra 2019).

Known safer alternatives are preferable during lactation, especially during the neonatal period and in the case of prematurity (Burch 2020 and 2019, Worthington 2013).


Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Butalbital is also known as

Butalbital in other languages or writings:


Butalbital belongs to these groups or families:


Main tradenames from several countries containing Butalbital in its composition:


Variable Value Unit
Oral Bioavail. 100 %
Molecular weight 224 daltons
Protein Binding 45 %
VD 0,8 l/Kg
pKa 8,48 -
Tmax 1 - 2 hours
T1/2 35 - 61 hours


  1. Suddock JT, Cain MD. Barbiturate Toxicity. 2020 Jul 2. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Abstract
  2. Burch R. Epidemiology and Treatment of Menstrual Migraine and Migraine During Pregnancy and Lactation: A Narrative Review. Headache. 2020 Jan;60(1):200-216. Abstract
  3. Burch R. Headache in Pregnancy and the Puerperium. Neurol Clin. 2019 Feb;37(1):31-51. Abstract
  4. Vohra V, Marraffa JM. Maternal use of acetaminophen-butalbital-caffeine product resulting in neonate butalbital exposure through breast milk. Abstract 273 in 39th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 21-24 May 2019, Naples, Italy, Clin Toxicol. 2019;57:127.
  5. Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ; Canadian Headache Society Acute Migraine Treatment Guideline Development Group. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80. Review. Abstract Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM